HIGHLIGHTS
- who: Aya El Helali from the DepartmentThe University have published the research work: A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer, in the Journal: Scientific Reports Scientific Reports of 29/Oct/2021
- what: The authors demonstrate the probable lack of efficacy of anti-angiogenic agents in non-high-risk chemotherapy naïve and platinum-sensitive EOC.
SUMMARY
Keys for (a, b): Bev_C Bevacizumab (concurrent), Bev_CM Bevacizumab (concurrent + maintenance), Car/Pac Carboplatin/Paclitaxel, Nin_CM Nintedanib (concurrent + maintenance), Tre_CM Trebananib (concurrent + maintenance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.